Raltegravir: molecular basis of its mechanism of action

about

A symmetric region of the HIV-1 integrase dimerization interface is essential for viral replication Integrase inhibitors: why do we need a new drug class for HIV therapy?Raltegravir flexibility and its impact on recognition by the HIV-1 IN targets.

P2860

Q28483813-626A8383-6411-4E3C-B70D-68CB36733B7A Q36452175-E3CFF596-B719-4F88-956F-C959686E71EA Q42285229-6D0947B6-C863-46C8-9904-45056C738472

P2860

Raltegravir: molecular basis of its mechanism of action

Item

http://www.wikidata.org/entity/Q36452171

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Raltegravir: molecular basis of its mechanism of action

@ast

Raltegravir: molecular basis of its mechanism of action

@en

type

Item

label

Raltegravir: molecular basis of its mechanism of action

@ast

Raltegravir: molecular basis of its mechanism of action

@en

prefLabel

Raltegravir: molecular basis of its mechanism of action

@ast

Raltegravir: molecular basis of its mechanism of action

@en

P1476

Raltegravir: molecular basis of its mechanism of action

@en

P2093

Jean-Francois Mouscadet

http://www.w3.org/2001/XMLSchema#string

Luba Tchertanov

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 integrase crosslinked oligomers are active in vitro

Protection of retroviral DNA from autointegration: involvement of a cellular factor

The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design

Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding

Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.

Two-metal active site binding of a Tn5 transposase synaptic complex

Solution structure of the DNA binding domain of HIV-1 integrase

Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity

Solution structure of the N-terminal zinc binding domain of HIV-1 integrase

P2888

2047-783x-14-s3-5

P304

5-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/2047-783X-14-S3-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

14 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2009-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51440406

http://www.w3.org/2001/XMLSchema#string

P6179

1005521440

http://www.w3.org/2001/XMLSchema#string

P698

19959411

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

mechanism of action

P932

3516820

http://www.w3.org/2001/XMLSchema#string

Raltegravir: molecular basis of its mechanism of action

about

P2860

P2860

Raltegravir: molecular basis of its mechanism of action

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P921

P932